Drugs / hCG
last change May 2020 re-read 2 minutes ago

hCG

Developed for
hypogonadotropic hypogonadism
Investigated by
Organon and Co

Trials 1 · a red edge is where a trial was stopped

2017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT03019575 Feb 2017 → May 2020 hypogonadotropic hypogonadism Organon and Co Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as hCG ClinicalTrials.gov intervention name — accepted as the source's own label NCT03019575
Route Subcutaneous “as a SC injection twice a week for 52 weeks” NCT03019575